Mitoxantrone Injection, Solution, Concentrate
Product Images NDC 71288-178

This text provides detailed information about the medication MitoXANTRONE injection, USP, which is a concentrate containing 20 mg per 10 mL (2 mg per mL). It is intended for intravenous infusion after dilution and comes in a sterile 10 mL multiple-dose vial. The text includes instructions on storage, cautionary notes, prescribing information, and manufacturer details. Pharmacies are advised to dispense the enclosed Medication Guide to each patient. It is important to follow safe cytotoxic agent handling procedures when using this medication.*

This text contains information about a medication called "MitoXANTRONE" in the form of an injection concentrate. It provides details such as the concentration (2mg per ml), total content in the vial (20 mg per 10 mL), recommended administration route (Intravenous Infusion), and instructions for dilution before use. The text also includes the product being a sterile, multiple-dose vial with a specific NDC code: NDC71288-178-10.*

This text appears to be a detailed description of a medication called MitoXANTRONE, an injection concentrate containing 25 mg per 12.5 mL (2 mg per mL). It is intended for intravenous infusion after dilution and comes in a sterile 1x12.5 mL multiple-dose vial. The inactive ingredients include sodium chloride, sodium acetate anhydrous, glacial acetic acid, and water for injection. The storage instructions recommend storing it between 20°C to 25°C (68°F to 77°F), cautioning against freezing and limiting storage duration. The container closure does not use natural rubber latex. The text also provides guidance for dispensing the medication guide to each patient.*